$LFLY
Leafly Holdings, Inc. /DE Stock $lfly

$lfly Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024039515 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$9.048M	$9.745M	$42.25M
YoY Change	-19.57%	-19.54%	-10.79%
Cost Of Revenue	$976.0K	$1.054M	$4.801M
YoY Change	-27.49%	-27.26%	-18.07%
Gross Profit	$8.072M	$8.691M	$37.45M
YoY Change	-18.49%	-18.49%	-9.76%
Gross Profit Margin	89.21%	89.18%	88.64%
Selling, General & Admin	$7.407M	$6.853M	$34.65M
YoY Change	-35.99%	-44.11%	-36.44%
% of Gross Profit	91.76%	78.85%	92.53%
Research & Development	$2.413M	$1.715M	$9.848M
YoY Change	-26.43%	-57.77%	-34.29%
% of Gross Profit	29.89%	19.73%	26.3%
Depreciation & Amortization	$329.0K	$286.0K	$986.0K
YoY Change	68.72%	65.32%	119.6%
% of Gross Profit	4.08%	3.29%	2.63%
Operating Expenses	$9.820M	$8.568M	$44.50M
YoY Change	-33.88%	-47.51%	-35.98%
Operating Profit	-$1.748M	$123.0K	-$7.051M
YoY Change	-64.67%	-102.17%	-74.82%
Interest Expense	-$607.0K	-$621.0K	-$2.778M
YoY Change	-14.87%	-10.26%	-1.17%
% of Operating Profit		-504.88%
Other Income/Expense, Net	-$32.00K	$43.00K	$331.0K
YoY Change	966.67%	-92.64%	-135.33%
Pretax Income	-$2.387M	-$455.0K	-$9.498M
YoY Change	-55.77%	-92.11%	-287.34%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.387M	-$455.0K	-$9.498M
YoY Change	-55.77%	-92.11%	-287.34%
Net Earnings / Revenue	-26.38%	-4.67%	-22.48%
Basic Earnings Per Share	-$1.09		-$4.74
Diluted Earnings Per Share	-$1.09	-$0.22	-$4.74
COMMON SHARES
Basic Shares Outstanding	2.301M	2.178M	2.006M
Diluted Shares Outstanding	2.196M		2.006M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.10M	$15.29M	$15.29M
YoY Change	-5.72%	-37.82%	-37.83%
Cash & Equivalents	$14.10M	$15.29M	$15.29M
Short-Term Investments
Other Short-Term Assets	$47.00K	$1.074M	$1.074M
YoY Change	51.61%	1412.68%	-48.86%
Inventory
Prepaid Expenses
Receivables	$2.152M	$2.635M	$2.635M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.48M	$19.00M	$19.00M
YoY Change	-20.49%	-37.55%	-36.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.436M	$2.554M	$2.554M
YoY Change	-7.09%	11.77%	11.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$279.0K	$279.0K
YoY Change	-90.0%	106.67%	-30.25%
Total Long-Term Assets	$2.694M	$2.833M	$2.833M
YoY Change	-9.29%	23.98%	4.93%
TOTAL ASSETS
Total Short-Term Assets	$18.48M	$19.00M	$19.00M
Total Long-Term Assets	$2.694M	$2.833M	$2.833M
Total Assets	$21.17M	$21.84M	$21.84M
YoY Change	-19.23%	-33.25%	-33.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$640.0K	$813.0K	$813.0K
YoY Change	-47.71%	-49.97%	-49.19%
Accrued Expenses	$3.608M	$2.503M	$2.503M
YoY Change	-22.61%	-59.86%	-59.63%
Deferred Revenue	$1.877M	$1.764M
YoY Change	-13.9%	-9.91%
Short-Term Debt	$1.399M	$0.00
YoY Change
Long-Term Debt Due	$29.22M
YoY Change
Total Short-Term Liabilities	$35.35M	$5.080M	$5.080M
YoY Change	338.21%	-48.26%	-48.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$29.09M	$29.09M
YoY Change	-100.0%	0.77%	0.64%
Other Long-Term Liabilities	$96.00K	$128.0K	$128.0K
YoY Change	-43.86%	-70.78%	-68.0%
Total Long-Term Liabilities	$96.00K	$29.21M	$29.21M
YoY Change	-99.67%	-0.3%	-0.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.35M	$5.080M	$5.080M
Total Long-Term Liabilities	$96.00K	$29.21M	$29.21M
Total Liabilities	$35.44M	$34.29M	$34.29M
YoY Change	-4.82%	-12.34%	-12.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.59M	-$74.20M
YoY Change	9.26%	14.68%
Common Stock	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.27M	-$12.46M	-$12.46M
YoY Change
Total Liabilities & Shareholders Equity	$21.17M	$21.84M	$21.84M
YoY Change	-19.23%	-33.25%	-33.23%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.387M	-$455.0K	-$9.498M
YoY Change	-55.77%	-92.11%	-287.34%
Depreciation, Depletion And Amortization	$329.0K	$286.0K	$986.0K
YoY Change	68.72%	65.32%	119.6%
Cash From Operating Activities	-$873.0K	$1.036M	-$8.604M
YoY Change	-90.53%	-135.02%	-69.37%
INVESTING ACTIVITIES
Capital Expenditures	$211.0K	$305.0K	$1.345M
YoY Change	-60.56%	10.51%	-45.55%
Acquisitions
YoY Change
Other Investing Activities	$2.000K	-$1.000K	$29.00K
YoY Change
Cash From Investing Activities	-$209.0K	-$296.0K	-$1.316M
YoY Change	-60.93%	7.25%	-46.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$168.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-114.0K	92.00K	262.0K
YoY Change	-201.79%		-99.03%
NET CHANGE
Cash From Operating Activities	-873.0K	1.036M	-8.604M
Cash From Investing Activities	-209.0K	-296.0K	-1.316M
Cash From Financing Activities	-114.0K	92.00K	262.0K
Net Change In Cash	-1.196M	832.0K	-9.658M
YoY Change	-87.59%	-125.73%	176.5%
FREE CASH FLOW
Cash From Operating Activities	-$873.0K	$1.036M	-$8.604M
Capital Expenditures	$211.0K	$305.0K	$1.345M
Free Cash Flow	-$1.084M	$731.0K	-$9.949M
YoY Change	-88.88%	-122.6%	-67.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001785592
CY2023	dei	Entity Registrant Name EntityRegistrantName	Leafly Holdings, Inc. /DE
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39119
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2266022
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	113 Cherry Street, PMB 8815
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98104-2205
CY2023	dei	City Area Code CityAreaCode	206
CY2023	dei	Local Phone Number LocalPhoneNumber	455-9504
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2301495
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	San Jose, California
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15293000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24594000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1398000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	908000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3298000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1074000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1792000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	360000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	19002000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30044000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	93403000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89956000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74198000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2554000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2285000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	251000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	248000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	135000
CY2023Q4	us-gaap	Assets Assets	21835000
CY2022Q4	us-gaap	Assets Assets	32712000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	813000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1625000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2503000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6235000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1764000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1958000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5080000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9818000
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	29085000
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	28863000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29213000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29301000
CY2023Q4	us-gaap	Liabilities Liabilities	34293000
CY2022Q4	us-gaap	Liabilities Liabilities	39119000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2392568
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2163756
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	154055
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	154055
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	31663000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	31663000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64700000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12458000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6407000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21835000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32712000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42252000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47363000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	4801000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5860000
CY2023	us-gaap	Gross Profit GrossProfit	37451000
CY2022	us-gaap	Gross Profit GrossProfit	41503000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12504000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	27080000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9848000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14988000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22150000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27440000
CY2023	us-gaap	Operating Expenses OperatingExpenses	44502000
CY2022	us-gaap	Operating Expenses OperatingExpenses	69508000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7051000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-28005000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2778000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2811000
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	309000
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	36823000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-937000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9498000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5070000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.74
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.89
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.74
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.5
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2005549
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1754012
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2005549
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1887024
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6407000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9498000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2955000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12458000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8572000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5070000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3917000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	158000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	158000
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	29374000
CY2022	lfly	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	27997000
CY2022	lfly	Adjustments To Additional Paid In Capital Stockholder Contribution Of Debt Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockholderContributionOfDebtIssuanceCosts	924000
CY2022	lfly	Reverse Recapitalization Contingent Consideration Value ReverseRecapitalizationContingentConsiderationValue	-6867000
CY2022	lfly	Adjustments To Additional Paid In Capital Issuance Of Warrant Derivative Liability AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantDerivativeLiability	-3916000
CY2022	lfly	Reverse Recapitalization Forward Share Purchase Agreement Value ReverseRecapitalizationForwardSharePurchaseAgreementValue	-14170000
CY2022	lfly	Adjustments To Additional Paid In Capital Contingent Consideration Shareholder Earnout Rights AdjustmentsToAdditionalPaidInCapitalContingentConsiderationShareholderEarnoutRights	-26131000
CY2022	lfly	Adjustments To Additional Paid In Capital Settlement Of Forward Share Purchase Agreement Derivative Liability AdjustmentsToAdditionalPaidInCapitalSettlementOfForwardSharePurchaseAgreementDerivativeLiability	17841000
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	2163766
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6407000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9498000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5070000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	986000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	449000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2955000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3917000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2767000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1378000
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-61000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	546000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	506000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	0
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	243000
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	309000
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	36823000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-46000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2104000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1718000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-825000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	580000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-813000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	424000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3826000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-983000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-194000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-17000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8604000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28088000
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1345000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2470000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	29000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1316000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2470000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2023	lfly	Proceeds From Reverse Recapitalization Placed In Escrow And Restricted ProceedsFromReverseRecapitalizationPlacedInEscrowAndRestricted	0
CY2022	lfly	Proceeds From Reverse Recapitalization Placed In Escrow And Restricted ProceedsFromReverseRecapitalizationPlacedInEscrowAndRestricted	39032000
CY2023	lfly	Trust Proceeds From Reverse Recapitalization TrustProceedsFromReverseRecapitalization	0
CY2022	lfly	Trust Proceeds From Reverse Recapitalization TrustProceedsFromReverseRecapitalization	582000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	168000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2023	lfly	Repurchase Of Common Stock And Settlement Of Derivatives RepurchaseOfCommonStockAndSettlementOfDerivatives	0
CY2022	lfly	Repurchase Of Common Stock And Settlement Of Derivatives RepurchaseOfCommonStockAndSettlementOfDerivatives	31303000
CY2023	lfly	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0
CY2022	lfly	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	10761000
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	94000
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-17000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	262000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27065000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9658000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3493000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25202000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28695000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15544000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25202000
CY2023	lfly	Stockholder Contribution For Debt Issuance Costs StockholderContributionForDebtIssuanceCosts	0
CY2022	lfly	Stockholder Contribution For Debt Issuance Costs StockholderContributionForDebtIssuanceCosts	924000
CY2023	lfly	Repurchase Of Common Stock In Other Accrued Expenses RepurchaseOfCommonStockInOtherAccruedExpenses	0
CY2022	lfly	Repurchase Of Common Stock In Other Accrued Expenses RepurchaseOfCommonStockInOtherAccruedExpenses	360000
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	324000
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	33024000
CY2023	lfly	Forward Share Purchase Agreements Issued ForwardSharePurchaseAgreementsIssued	0
CY2022	lfly	Forward Share Purchase Agreements Issued ForwardSharePurchaseAgreementsIssued	14170000
CY2023	lfly	Warrants Issued WarrantsIssued	0
CY2022	lfly	Warrants Issued WarrantsIssued	3916000
CY2023	lfly	Contingent Consideration Shares Issued ContingentConsiderationSharesIssued	0
CY2022	lfly	Contingent Consideration Shares Issued ContingentConsiderationSharesIssued	6867000
CY2023	lfly	Stockholder Earnout Rights Shares Issued StockholderEarnoutRightsSharesIssued	0
CY2022	lfly	Stockholder Earnout Rights Shares Issued StockholderEarnoutRightsSharesIssued	26131000
CY2023	lfly	Outstanding Principal Amount OutstandingPrincipalAmount	300000
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0.05pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported net (loss) income</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses in the consolidated financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates. Such estimates include those related to the fair value of derivative liabilities; the allowance for credit losses; the valuation allowance for deferred income tax assets; the fair value of the convertible promissory notes; the estimate of capitalized software costs and useful life of capitalized software; and the fair value of equity issuances. Management bases its estimates on historical experience, knowledge of current events and actions it may undertake in the future that management believes to be reasonable under the circumstances. Actual results may differ from these estimates and assumptions.</span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents, restricted cash and accounts receivable. The Company’s cash and cash equivalents and restricted cash are deposited with major financial institutions primarily in the U.S. and Canada. At times, deposits in financial institutions may be in excess of the amount of insurance provided on such deposits by the FDIC, NCUA or CDIC. At December 31, 2023 and 2022, cash and cash equivalents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9,065</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">574</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, resp</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ectively, held in domestic and foreign institutions, were insured within the limitations set by the FDIC, NCUA or CDIC, as applicable. To date, the Company has not experienced any losses on its cash deposits.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts receivable are unsecured and the Company generally does not require collateral from its customers. The Company evaluates the collectability of its accounts receivable and provides an allowance for potential credit losses as necessary.</span></p>
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9848000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14988000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	93000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	3059000
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.035
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15293000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24594000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	360000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	251000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	248000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15544000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25202000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3298000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	908000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1848000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2767000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1378000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2277000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2318000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1398000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	908000
CY2023Q4	lfly	Prepaid Subscriptions PrepaidSubscriptions	568000
CY2022Q4	lfly	Prepaid Subscriptions PrepaidSubscriptions	916000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	350000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	533000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	82000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	272000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	74000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1074000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1792000
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	28000
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	135000
CY2023Q4	lfly	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	1102000
CY2022Q4	lfly	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	1927000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4102000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3050000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1548000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	765000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2554000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2285000
CY2023	lfly	Schedule Of Depreciation Expense Related To Fixed Assets Tabletext Block ScheduleOfDepreciationExpenseRelatedToFixedAssetsTabletextBlock	<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognized depreciation and amortization expense as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.993%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:12.883000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:12.883000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Depreciation expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">164</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of capitalized internal-use software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">902</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total depreciation and amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">986</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">449</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2023, the Company disposed of equipment with a bo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ok value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, resulting in a loss on disposal of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">61</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023	us-gaap	Depreciation Depreciation	84000
CY2022	us-gaap	Depreciation Depreciation	164000
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	902000
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	285000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	986000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	449000
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1309000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	969000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2403000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	999000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1000000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	535000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1523000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2503000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6235000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1958000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1975000
CY2023	lfly	Contract With Customer Liability Increase Decrease ContractWithCustomerLiabilityIncreaseDecrease	1595000
CY2022	lfly	Contract With Customer Liability Increase Decrease ContractWithCustomerLiabilityIncreaseDecrease	1942000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1789000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1959000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1764000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1958000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42252000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47363000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42252000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47363000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12500000
CY2023Q4	lfly	Market Value Of Listed Securities1 MarketValueOfListedSecurities1	10800000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9500000
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	lfly	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1
CY2023Q4	lfly	Board Of Directors Number Of Classes BoardOfDirectorsNumberOfClasses	3
CY2023	lfly	Board Of Directors Term BoardOfDirectorsTerm	P3Y
CY2023	lfly	Board Of Directors Term BoardOfDirectorsTerm	P3Y
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q1	lfly	Derivative Instrument Number Of Forward Share Purchase Agreements DerivativeInstrumentNumberOfForwardSharePurchaseAgreements	4
CY2022Q1	lfly	Derivative Instrument Forward Share Purchase Agreement Number Of Shares DerivativeInstrumentForwardSharePurchaseAgreementNumberOfShares	200000
CY2022Q1	lfly	Derivative Instrument Forward Share Purchase Agreement Term DerivativeInstrumentForwardSharePurchaseAgreementTerm	P3M
CY2022	lfly	Derivative Instrument Forward Share Purchase Agreement Proceeds From Release Of Restricted Cash DerivativeInstrumentForwardSharePurchaseAgreementProceedsFromReleaseOfRestrictedCash	8089000
CY2023Q4	lfly	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	4
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2955000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3917000
CY2022Q1	lfly	Share Based Compensation Arrangement By Share Based Payment Award Options Modified ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsModified	47880
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	1366000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6567000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	380000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1497000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9498000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	627000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	875000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42252000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47363000
CY2023	us-gaap	Gross Profit GrossProfit	37451000
CY2022	us-gaap	Gross Profit GrossProfit	41503000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9878000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5070000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	20288000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	20565000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1516000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1537000
CY2023Q4	lfly	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	10191000
CY2022Q4	lfly	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	11671000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4151000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0
CY2023Q4	lfly	Deferred Tax Assets Non Qualified Stock Options DeferredTaxAssetsNonQualifiedStockOptions	486000
CY2022Q4	lfly	Deferred Tax Assets Non Qualified Stock Options DeferredTaxAssetsNonQualifiedStockOptions	387000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	334000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	582000
CY2023Q4	lfly	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	1612000
CY2022Q4	lfly	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	1024000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	28000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38606000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35788000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38598000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35780000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2818000
CY2023Q4	lfly	Cumulative Change In Ownership Percentage CumulativeChangeInOwnershipPercentage	0.50
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1992000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1065000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-381000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	238000
CY2023	lfly	Income Tax Reconciliation Permanent Differences Amount IncomeTaxReconciliationPermanentDifferencesAmount	0
CY2022	lfly	Income Tax Reconciliation Permanent Differences Amount IncomeTaxReconciliationPermanentDifferencesAmount	0
CY2023	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-528000
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-266000
CY2023	lfly	Effective Income Tax Rate Reconciliation Rate Changes EffectiveIncomeTaxRateReconciliationRateChanges	-308000
CY2022	lfly	Effective Income Tax Rate Reconciliation Rate Changes EffectiveIncomeTaxRateReconciliationRateChanges	-329000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	21000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	7000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2818000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7753000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	187000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	195000
CY2023	lfly	Effective Income Tax Rate Reconciliation Fair Value Of Warrants Amount EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsAmount	-77000
CY2022	lfly	Effective Income Tax Rate Reconciliation Fair Value Of Warrants Amount EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsAmount	-9011000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	245000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	353000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	8000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9498000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5070000
CY2023	lfly	Derivative Instrument Income Statement Impact DerivativeInstrumentIncomeStatementImpact	0
CY2022	lfly	Derivative Instrument Income Statement Impact DerivativeInstrumentIncomeStatementImpact	-346000
CY2023	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-9498000
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4724000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2005549
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1754012
CY2023	lfly	Incremental Common Shares Attributable To Dilutive Effect Of Derivative Instruments IncrementalCommonSharesAttributableToDilutiveEffectOfDerivativeInstruments	0
CY2022	lfly	Incremental Common Shares Attributable To Dilutive Effect Of Derivative Instruments IncrementalCommonSharesAttributableToDilutiveEffectOfDerivativeInstruments	56984
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	76028
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2005549
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1887024
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.74
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.89
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.74
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.5
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1266494
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1195641
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000950170-24-039515-index-headers.html	Edgar Link	pending
0000950170-24-039515-index.html	Edgar Link	pending
0000950170-24-039515.txt	Edgar Link	pending
0000950170-24-039515-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lfly-20231231.htm	Edgar Link	pending
lfly-20231231.xsd	Edgar Link	pending
lfly-ex10_22.htm	Edgar Link	pending
lfly-ex21_1.htm	Edgar Link	pending
lfly-ex23_1.htm	Edgar Link	pending
lfly-ex31_1.htm	Edgar Link	pending
lfly-ex31_2.htm	Edgar Link	pending
lfly-ex32_1.htm	Edgar Link	pending
lfly-ex97_1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
lfly-20231231_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFLY
Leafly Holdings, Inc. /DE Stock $lfly

2024 Q1 Form 10-K Financial Statement

#000095017024039515 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFLY Leafly Holdings, Inc. /DE Stock $lfly

2024 Q1 Form 10-K Financial Statement

#000095017024039515 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFLY
Leafly Holdings, Inc. /DE Stock $lfly